MedTrace Logo

Vitamin D3 For CGD Patients With BCGosis/Itis

NCT03984890 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-07-09

No results posted yet for this study

Summary

When children with chronic granulomatous disease (CGD) got BCG infection the treatment would be a tough task. The goal of the proposed research is to observe weather vitamin D supplementation can help the CGD children get through this challenge.

Conditions

  • Vitamin D3
  • Chronic-granulomatous Disease
  • BCG

Interventions

DRUG

Vitamin D3

Vitamin D3 drops 800IU/d for 3 months

DRUG

Traditional treatment of CGD and TB

Anti-tuberculosis drugs, interferon-gamma

Sponsors & Collaborators

  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Weili Yan, Ph.D · Children's Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03984890 on ClinicalTrials.gov